GMO: Sink or Swim?
Will the new wave of AI-related investment float the market or sink it?
Hype vs. High Conviction
A Quality Approach to Investing in AI.
Valuing AI: Extreme Bubble, New Golden Era, or Both
by Jeremy Grantham and Edward Chancello, GMO LLC Part 1 Valuing AI: Extreme Bubble, New Golden Era, or Both…
Artificially Inflated
by The Asset Allocation Team, GMO LLC The Danger of Today’s 10x “Opportunity” As enthusiasm for artificial intelligence…
Improving On The Traditional 60/40 Allocation
by Ben Inker, Co-Head of Asset Allocation, Portfolio Manager, GMO LLC The traditional 60/40 portfolio (60% equities, 40%…
It’s Probably a Bubble, But There Is Plenty Else to Invest In
An Agnostic Investor’s Playbook
Asset Allocation Is Easy in Theory, Difficult in Practice
by Ben Inker, GMO LLC In theory, growing a pool of wealth over decades — whether for a…
A Second Opinion on the 60/40 Default
by Ben Inker, GMO LLC Asset Allocation Is Easy in Theory, Difficult in Practice In theory, growing a…
Time to Take Another Look at Alternatives
by Asset Allocation Team, GMO LLC Some investors still shudder when they consider their experience with hedge funds.…
Many Happy (Fundamental) Returns
by Tom Hancock, Anthony Hene and Ty Cobb, GMO LLC There aren’t many laws of investing, but our…
GMO: American Unexceptionalism
by Ben Inker and John Pease, GMO LLC Executive Summary Investors today take for granted that the S&P…
Frenzied Speculation in U.S. Stocks
How to Exploit or Protect Against It
Value: That Was Then, This is Now
by Asset Allocation Team, GMO LLC At GMO, we are valuation-sensitive investors — not reflexive “value” investors. That…
Trade: The Most Beautiful Word in the Dictionary
by Ben Inker Co-Head, Asset Allocation, and John Pease, Asset Allocation Team, GMO LLC The global trade situation…
Three Reasons we’re Overweight Japanese Equities
by Rick Friedman and John Thorndike, GMO LLC In a world of rich valuations and heightened geopolitical uncertainties,…